Matt Hervey is Head of Artificial Intelligence (UK) and advises on Artificial Intelligence (AI) across all sectors, including automotive, life sciences, finance and retail. He is joint General Editor of The Law of Artificial Intelligence (by Sweet & Maxwell). Matt was made a Fellow of the Royal Society of Arts in 2022 in recognition of his leadership in the field of AI. He is in AI-related working groups for the IP Federation, the International Association for the Protection of Intellectual Property (AIPPI), the American Intellectual Property Law Association (AIPLA), the International Chamber of Commerce (ICC) and the World Law Group.
Matt is a trusted intellectual property adviser, especially for clients with complex patent disputes, including SEP (FRAND) litigation. He is described as "stand out" and "absolutely superb" for patent disputes (Legal 500).
His cases have involved video compression, telecommunications (2G, 3G, LTE, DSL and others standards), aircraft design, software (algorithmic trading, consumer share trading platforms, 3D modelling), consumer electronics (inkjet printers), location sensing and traffic analysis. He has extensive experience of healthcare and Life Sciences work including monoclonal antibodies, biosimilars, toxins, medical devices and cosmetics. Matt has handled product clearances and disputes involving copyright, trademarks, designs and confidential information for clients in the aerospace, retail, fashion, automotive and financial services sectors.
Matt managed the litigation team that successfully defended three patents of the Kennedy Trust for Rheumatology Research in the first 'biosimilar' patent litigation in the UK. He managed one of the cases for Fujifilm Kyowa Kirin Biologics Co., Ltd leading to the first granted "Arrow" declaration in the UK. He also has experience of high-value arbitration.